p53 protein is a sequence-speci®c transcriptional activator which induces the expression of a number of cellular genes involved in dierent metabolic pathways. We report that the computer-selected sequence in human and mouse C-Ha-Ras gene confers to a reporter gene the ability to be directly transactivated by wild-type p53 either over- 
Introduction
Mutation of the p53 tumour suppressor protein is the most common genetic alteration known to occur in human cancers. The major consequences of such mutations are the inactivation of the biological and biochemical functions of p53. Wild-type p53 protein is involved in several biological functions such as replication, senescence, dierentiation and DNA repair. But the well-known biological functions of p53 are the induction of either cell cycle arrest or apoptosis in response to a variety of insults that involve DNAdamaging agents such as ionizing and UV radiations, as well as less obvious DNA-damaging agents such as serum starvation, ribonucleotide depletion, hypoxia and expression of oncogenes (myc, E1A). These functions depend in large part on its biochemical ability to modulate gene expression (see references in May and May, 1999; Ko and Prives, 1996; Levine, 1997) . The wild-type p53 protein is a positive transcription factor which, in response to cellular stress, binds in a sequencespeci®c manner to a DNA motif and induces the expression of genes containing such a motif in their promoter or intron (Funk et al., 1992; El-Deiry et al., 1992) . Moreover, p53 can repress the transcription of other genes seemingly in both sequence-speci®c and nonspeci®c manner. Identi®cation of transcriptional targets of p53 is critical in discerning the distinct pathways by which p53 aects cellular outcome such as growth arrest and death. Tokino et al. (1994) have estimated at 200 to 300 the total number of p53-responsive elements in the whole human genome, a number of them have not yet been identi®ed. This led us to develop a computer approach, which allows potential p53 target genes to be identi®ed in the GenBank database (Bourdon et al., 1997) . This computer-assisted approach permits identi®cation of a p53-binding element in the ®rst intron of the c-Ha-Ras gene of various species, suggesting a direct p53-mediated activation of this gene.
Cellular stress and activation of growth factor receptors by ligand binding initiate a cascade of events from the cytoplasmic membrane to the nucleus leading to a cellular response. The protein p21 c-Ha-Ras is involved in this signal transduction by activating several cascades of kinases (Raf, PI3 kinase, Cdc42, Rac, MEKK1, PKCz) which lead cells to growth, dierentiation, apoptosis or senescence (see references in Campbell et al., 1998) . Recently, it has been reported that p21 c-Ha-Ras protein plays a key role in integrating mitogenic signals to induce G1 arrest (Peeper et al., 1997; Olson et al., 1998) . Expression of Ras oncogene in normal primary cells causes a cell-cycle arrest that involves the activation of the tumour suppressor protein p53 (Serrano et al., 1997) .
In the present study, we present evidence for the involvement of p21 c-Ha-Ras signalling pathways in p53-dependent transcriptional activity and apoptosis. We propose that p53 activates a feedback loop via c-HaRas transactivation that, depending on the cellular context, modulates p53 activities.
Results
Wild-type p53 binds specifically to a p53-responsive element identified in the human c-Ha-Ras gene
We have identi®ed by computer analysis a putative p53-responsive element (p53RE) in the 5'-end of the ®rst intron of the human c-Ha-Ras gene (Bourdon et al., 1997) . It comprises actually eight decamers and includes the p53RE previously identi®ed by Zhang et al. (1995) and Spandidos et al. (1995) as comprising two or three decamers, respectively ( Figure 1A ). Here we extend this investigation to other species. We identi®ed, at the same gene location, a putative p53RE in the ®rst intron of the rat (seven decamers), mouse (seven decamers) and rabbit (at least ®ve decamers) c-Ha-Ras gene ( Figure 1B) .
To determine whether the p53 protein could bind speci®cally to the human sequence comprising eight consensus decamers, we performed EMSA with the DdeI-117-bp 32 P-labelled DNA fragment ( Figure 1A ) and the wild-type p53 protein puri®ed from an extract of Sf9 cells infected with a recombinant baculovirus. The results presented in Figure 2 reveal two complexes which were supershifted when PAb1801 was added to the reaction mixture (compare lanes 1 and 7), indicating that p53 was present in the dierent DNAprotein complexes. A 200-fold molar excess of a cold oligonucleotide corresponding to a perfect p53 consensus sequence competed with the labelled probe (lanes 3 and 10). In contrast, this eect was not observed when 200-fold molar excess of a cold oligonucleotide containing no p53 consensus sequence was used as competitor (lanes 6 and 13).
c-Ha-Ras decamers are responsive to wt-p53 in a dose-dependent manner To determine whether c-Ha-Ras p53RE can confer to a reporter gene the ability to be transactivated by wt-p53 the luciferase expression recombinant pRasH-Adluc containing a 315-bp DNA fragment from intron 1 of human c-Ha-Ras gene was constructed. This construct was used in the dual luciferase gene reporter assay by transfecting H1299 cells. As shown in Figure 3A , the luciferase activity derived from pRasH-Adluc was induced 10 ± 20-fold in a dose-dependent manner by wt-p53. No induction of the luciferase activity was observed after co-transfection with mutant pCMVp53His175. The luciferase activity coded by the control plasmid pAdluc was neither stimulated nor repressed by wt-p53.
The plasmid pRasH-Adluc was then transfected in Saos-2Ts cells that express the human ts mutant, p53Val138, and in control Saos-Neo cells which do not express p53. The results given in Figure 3B show that reactivation of wt-p53 by temperature shift resulted in a p53-dependent luciferase reporter gene expression.
Taken together, these results show that the 315-bp DNA fragment of the human c-Ha-Ras intron 1 confers to a minimal promoter the ability to be transactivated by wt-p53.
Similar results were obtained with the p53RE element identi®ed by computer-assisted analysis, in the intron 1 of the mouse c-Ha-Ras gene. This putative p53RE containing seven p53 consensus decamers ( Figure 1B ) was inserted upstream of the minimal adenovirus major late promoter fused to ®re¯y luciferase gene to generate pRasM-Adluc recombinant. The results presented in Figure 4 show that the luciferase activity is p53 dose-dependent in cells transfected with the pRasM-Adluc recombinant, but Figure 1 The c-Ha-Ras proto-oncogene contains a p53RE conserved through evolution. (A) Sequence ampli®ed from intron 1 of the human c-Ha-Ras gene. The numbering is according to the GenBank sequence: HUMRASH. p53 decamers are in upper case letters and DdeI restriction sites are underlined. The boxed sequence corresponds to the p53RE element identi®ed by Spandidos et al. (1995) , the underlined one in the box to that reported by Zhang et al. (1995) . (B) P53RE were identi®ed by the computer approach previously described (Bourdon et al., 1997) in sequences OCHRAS1 (rabbit), HUMRASH (human) and RA-TRASH (rat) of GenBank and in the mouse c-Ha-Ras gene sequence published by Brown et al. (Brown et al., 1988) . p53 consensus decamers are written in underlined, upper case letters Figure 2 Speci®c binding of p53 to the eight decamers identi®ed in intron 1 of the human c-Ha-Ras gene. The puri®ed baculovirus-produced wild-type human p53 was incubated with the Klenow 32 P-end-labelled 117-bp fragment containing the eight p53 consensus decamers, in the presence of 250 fmol of unlabelled non-consensus double-strand oligonucleotide (NS) and, when indicated, with PAb1801. Competitions involved the use of 20-(lanes 2, 4, 8 and 11), 50-(lanes 3, 5, 9, 12) or 200-fold (lanes 6, 10, 13) molar excess of unlabelled double-stranded oligonucleotide of either the p53-consensus sequence (S) (lanes 2, 3, 8, 9, 10) or a non-speci®c sequence (NS) (lanes 4, 5, 6, 11, 12, 13) not in cells transfected with the control pAdluc plasmid. We conclude that there is a functional p53RE in the intron 1 of human as well of the mouse c-Ha-Ras gene. This suggests that the ability of p53 to transactivate the c-Ha-Ras gene expression is conserved through evolution.
The human c-Ha-Ras p53RE is responsive to endogenous wt-p53 activated by various stress, in U-2OS
To further analyse the eect of wt-p53 protein on the human c-Ha-Ras RE, p53-negative Saos-2 cells stably transfected with pRasH-Adluc (or pAdluc as a negative control) were compared with the wild-type p53-expressing U-2OS cells stably transfected with the same luciferase reporter constructs. Cells were treated 24 h after seeding with three genotoxic agents known to activate wt-p53 : H7, an inhibitor the protein kinase C or one of the two DNA intercalating agents, Actinomycin D and Doxorubicin. Cells were harvested 24 h after treatment and analysed for luciferase activity. The results are presented in Table 1 . Compared to the non-treated cells, the luciferase activity of U2OS-Rasluc cells was signi®cantly increased by treatment either with H7 (2 ± 3-fold) or Doxorubicin (more than ®vefold) or Actinomycin D (more than 12-fold). No such stimulation was observed by analysing U2OS-Adluc cells or the p53 negative cells Saos-Rasluc. To make sure that pRasH-Adluc recombinant was functional in Saos-Rasluc cells, we have controlled the ability of these cells to support the induction of luciferase activity by reintroducing expression of wt-p53 protein by transient transfection (data not shown). We then conclude that the human cHa-Ras p53RE confers to a minimum promoter the ability to be transactivated by physiological level of activated wt-p53.
The endogenous c-Ha-Ras gene expression is stimulated in Saos-2Ts by wt-p53 activation following permissive temperature shift down
In order to determine if the endogenous c-Ha-Ras gene could be induced by wt-p53 in vivo, we analysed the expression of c-Ha-Ras gene in Saos-2Ts cells. These cells expressed the human p53val138 thermosensitive mutant which adopts a wt conformation at 328C and a mutant one at 388C. The expression of a reporter gene driven by a promoter including a p53RE (such as waf1, mdm2, GADD45) is activated in Saos-2Ts cells after a temperature shift down from 388C to 328C, but not in control Saos-Neo cells (Yamato et al., 1995 and our data not shown). We took advantage of this cellular model to analyse the p53-dependent mRNA expression of the endogenous c-Ha-Ras gene. A representative Northern blot is given in Figure 5A1 . The relative level of c-Ha-Ras mRNA was estimated as described in the Figure 5 legend. The mRNA level of c-Ha-Ras was increased twofold by transferring Saos-2T cells to 328C for 8 h to 24 h ( Figure 5A2 ). Indeed endogenous c-HaRas gene expression was already stimulated 3 h after the temperature drop (data not shown). No such increase was observed with the control Saos-Neo cells that did not express p53, indicating that the upregulation of c-Ha-Ras gene expression seen in Saos2Ts cells after temperature shift down is p53-speci®c.
Comparable results were obtained with cells preincubated at 388C in DMEM supplemented with 0.5% FCS for 40 h ( Figure 5B1 , 2). Comparison of these two sets of experiments suggests that the p53-dependent transactivation of the endogenous c-Ha-Ras gene is independent of serum stimulation, at least under our experimental conditions. We were then interested to examine if the stimulation of c-Ha-Ras gene transcription was followed by a concomitant increase in p21 c-Ha-Ras protein. To this aim, Figure 3 The intron 1 sequence of human c-Ha-Ras gene containing the eight p53 consensus decamers confers on a reporter gene the ability to be transactivated by wt-p53. (A) H1299 cells were co-transfected with 2.5 mg/ml of pRasH-Adluc or pAdluc and with 50 ng/ml of pSVE-RenLuc (as internal control) and 0 (lanes 1 and 5), 0.25 (lanes 2 and 6) and 0.75 (lanes 3 and 7) mg/ml of pCMVhump53 or 0.75 mg/ml of pCMVp53His175 (lanes 4 and 8). The averaged results are of three independent experiments performed in triplicate. Standard deviations are indicated. (B) 7.5 mg/ml of pRasH-Adluc or pAdluc was transfected either in Saos-2Ts cells (Ts), or in the control Saos-Neo cells (C), and maintained at 388C for 6 h. The DNA precipitate was washed and the cells were re-fed with DMEM supplemented with 10% FCS, and either maintained at 388C (open bars) or transferred to 328C (black bars) for 18 h (to activate wt-p53). The cell extract was prepared and the luciferase activity was measured as described in Materials and methods. Luciferase activity at 328C was expressed relative to the luciferase activity of cells transfected under the same conditions but maintained at 388C Figure 4 The intron 1 sequence of mouse c-Ha-Ras gene containing the six p53 consensus decamers confers on a reporter gene the ability to be transactivated by wt-p53. 2.5 mg/ml of pRasM-Adluc or pAdluc were co-transfected with 50 ng/ml of pSVE-RenLuc (as internal control) and 0 (lanes 1 and 5), 0.1 (lanes 2 and 6), 0.25 (lanes 3 and 7) and 0.5 (lanes 4 and 8) mg/ml of pCMVhump53. Transfection and luciferase activity measurements were performed as described in the legend to Figure 3A .
The averaged results are of three independent experiments performed in triplicate. Standard deviations are indicated
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Transactivation of c-Ha-Ras by p53 and apoptosis V Deguin-Chambon et al levels of p21 c-Ha-Ras protein extracted from Saos-2Ts and Saos-neo cells treated as described in the legend to Figure 5 , were estimated by precipitation with GST-RBD to identify activated p21 c-Ha-Ras (Ras.GTP). As shown in Figure 5C , there is a substantial increase in the level of activated c-Ha-Ras protein in Saos-2Ts cells transferred to 328C compared to what was obtained with Saos-2Ts cells maintained at 388C or with control Saos-Neo cells either maintained at 388C or transferred to 328C. This increase speci®cally observed in Saos-2Ts cells transferred to 328C is also noticeable by Western blot of total protein extract, although to a lesser extent (data not shown). Control experiments were performed with H1299 cells expressing by transient transfection the constitutive GTPbound mutant, Ha-RasV12 or the dominant negative mutant RasN17. As shown in Figure 5C , only HaRasV12 protein is retained on GST-RBD. We then conclude that the p53-dependent up-regulation of cHa-Ras gene transcription is accompanied by a concomitant increase in p21 c-Ha-Ras level that leads to a higher cellular level of Ras.GTP.
Activation of wt-p53 expressed in SK-N-SH cells leads to an increase in the intracellular level of p21 c-Ha-Ras
The next step was designed to investigate if the cellular level of p21 c-Ha-Ras might increase following treatment with a DNA damaging agent, in a cellular model that responds to p53 activation by apoptosis. Several neuroblastoma cell lines expressing wt-p53 have been shown to undergo apoptosis following exposure to agents that induce nuclear p53 accumulation such as H7 (Ronca et al., 1997) , leptomycin B (Smart et al., 1999) or UVC (Bourdon, unpublished data) . Comparison of the two SK-N-SH derived cell lines, the wt-p53 expressing SKNSH-CMVneo and the SKNSH-DDp53 that overexpresses a dominant negative truncated p53, clearly showed that the induction of apoptosis is p53-dependent (Smart et al., 1999) . We c-HaRas protein levels. In order to test whether the eects of UVC on SKNSH-CMVneo cells depended on the p53 function, control experiments were undertaken using SKNSH-DDp53 cells. As already reported and as shown in Figure 6 , the level of endogenous p53 increased owing to the expression of the murine p53 dominant negative mutant. It has already been reported that the activity of p53 as a transcriptional activator is abrogated since the p21 WAF1 protein was not detected after leptomycin B treatments (Smart et al., 1999) . As expected, UVC did not lead to an increase in p21 c-Ha-Ras protein level in SKNSH-DDp53, showing that the signi®cant increase in p21 c-Ha-Ras protein level following SK-N-SH cell-UVC irradiation is brought about by the activation of wt-p53 expressed in these cells.
Overexpression of RasN17, a dominant interfering mutant of p21 c-Ha-Ras , reduced the level of p53-dependent induction of apoptosis
We previously showed that overexpression of wt-p53 in HeLa and H1299 cells caused transfected cells to undergo apoptosis (Yonish-Rouach et al., 1994 . In the present study, we used this approach to further investigate the involvement of p53-dependent c-Ha-Ras gene transactivation in the ability of p53 to induce apoptosis. To this aim a plasmid encoding the wt-p53 was cotransfected with the dominant interfering HaRasN17 mutant (Feig and Cooper, 1988) . The coexpression of RasN17 did not signi®cantly change the percentage of p53-positive cells as compared to culture transfected with p53 only, indicating that RasN17 has no cytotoxic eect (data not shown). The percentage of apoptotic cells was evaluated by cytometry and corresponds to the percentage of p53-positive cells having a DNA content less than those in G1. Apoptotic cells represented 20% to 25% of H1299 or HeLa p53-positive cells (Figure 7 ). This percentage dropped to 5% (or less) for the p53-positive population expressing the p53-Ser249 mutant. Coexpression of RasN17 with wt-p53 lowered the percentage of apoptotic bodies to 5% and 10% in HeLa and H1299 cells, respectively. These results strongly suggest that p53-dependent induction of apoptosis in transfected cells involves activation of p21 c-Ha-Ras .
RasN17 overexpression reduced the wt-p53 transcriptional activity
To investigate the eect of RasN17 on the transcriptional activity of p53, RasN17 was coexpressed in H1299 cells with the reporter gene and with (or without) wt-p53. Luciferase activities were analysed 24 h after transfection. The results presented in Figure  8A ,B show that coexpression of RasN17 signi®cantly reduced the p53-stimulated luciferase activity driven either by waf or Bax p53-responsive promoter, although the basal activities of these two reporter plasmids were not diminished by the coexpression of RasN17, in the absence of p53 expression (results not shown). Similar results were obtained in Saos-2 and HeLa cells (data not shown). This eect was also observed 24 h after transfection with lower levels of p53 (500 ng/ml of pSVEhump53) and RasN17 (1 mg/ml of pSVE-RasN17) (data not shown). One possible explanation would be an inhibitory eect of RasN17 on p53 expression from pSVEhump53. We then checked that the transcriptional activity of the SV40 early promoter was not aected by the co-expression of RasN17. To this end, we substituted the p53 coding sequence of the pSVEhump53 by the luciferase gene to generate pSVE-luc. The results given in Figure 8C show that luciferase activities measured in extracts of cells transfected by pSVE-luc were not aected by the co-expression of RasN17. These results strongly suggest that the diminution of luciferase activity Saos-2Ts and Saos-Neo cells were seeded in 9-cm Petri dishes. After 24 h at 388C in DMEM supplemented with 10% FCS, the cells were re-fed with fresh medium supplemented with 0.5% FCS and maintained at 388C for an additional 40 h before being transferred to 328C. After 24 h at 328C, the cells were re-fed with fresh medium supplemented with 10% FCS and maintained an additional 1 h at 328C. Parallel cultures were maintained at 388C. Activated p21 c-Ha-Ras was identi®ed as described in Materials and methods. A monoclonal antibody to Ha-Ras was used to detect Ras. The blot was developed by the enhanced chemiluminescence method (E.C.L. method, Amersham). As control, H1299 cells transfected either with 10 mg of control vecteur pBS (C), pSVE-RasN17 (N17) or pHO6T1 (V12) and extracted 24 h after addition of DNA, were treated in parallel Figure 6 Western analysis of p53 and p21 c-Ha-Ras protein pro®les following UVC irradiation. SKNSH-CMVneo and SKNSHDDp53 cells were exposed to 30 J/m 2 UVC and cells were lysed at the indicated times. Whole cell extracts (30 mg of total protein) were run on a 15% SDS ± PAGE. After Western transfer, membranes were probed using in succession: CM1 polyclonal anti-human p53 (top panel), anti-p21 c-Ha-Ras (second panel) and anti-actin (bottom panel) monoclonal antibodies, as described in Materials and methods. In the upper panel, the endogenous human p53 (53 Kd) and the truncated dominant negative mutant (20 Kd) were indicated by an arrow and their respective sizes Figure 7 Eect of a c-Ha-Ras dominant interfering mutant, RasN17, on p53-dependent induction of apoptosis. The cells were transfected with 10 mg/ml of either pSVEhump53 (wt) or pSVEp53Ser249 (mut) with or without 20 mg/ml pSVE-RasN17. The percentage of apoptotic bodies was estimated by¯ow cytometry analysis for the p53-positive population 66 h post-transfection for
HeLa cells (A) or 48 h post-transfection for H1299 cells (b). A mean of six independent experiments is given with the standard deviation
Oncogene Transactivation of c-Ha-Ras by p53 and apoptosis V Deguin-Chambon et al observed by co-expressing p53 and RasN17 cannot be explained by a down-regulation of p53 expression by RasN17.
It was then interesting to determine if, contrary to RasN17, the co-expression of both an activated form of c-Ha-Ras and p53 could stimulate the activity of luciferase expressed under the control of a p53-responsive element. To this aim, the recombinant pHO6T1 encoding the oncogenic Ha-RasV12 protein was co-transfected in H1299 with the recombinant luciferase reporter plasmid PG13-luc and a plasmid encoding wt-p53. Results are presented in Figure 8D . The luciferase activity controlled by PG13-p53RE which comprises 13 decamers is strongly induced (120-fold) by wt-p53. As expected from previous results, this stimulation is signi®cantly reduced by the coexpression of RasN17. On the contrary, co-expression of Ha-RasV12 increased noticeably the p53-dependent stimulation of the luciferase activity. These results further support the implication of Ras activation in the regulation of p53-dependent transcriptional activity.
Overexpression of RasN17 reduces the expression of p53 transfected gene at the protein level
To examine the eect of RasN17 on p53 protein accumulation, H1299 cells were co-transfected with a constant amount of pSVEhump53 and an increasing amount of pSVE-RasN17. Twenty-four hours after transfection, cells from two Petri dishes were scraped in cool PBS and pooled. Half of them were lysed and the p53 level was estimated by Western blot analysis using DO7 antibody. Comparable amounts of loaded proteins were con®rmed by reprobing membranes with an anti-PCNA antibody. The results presented in Figure 9A are representative of at least ®ve independent experiments. They clearly show that a coexpression of RasN17 signi®cantly decreased the level of transfected p53 protein in a dose-dependent manner.
Total RNA was extracted from the other half of transfected cells and the p53 mRNA level was evaluated by Northern blot. A representative experiment is presented in Figure 9B . Contrary to the eect on p53 protein, the intracellular level of p53 speci®c mRNA evaluated by Northern blot analysis was unaected by the coexpression of RasN17. These results strengthened those presented in the previous paragraph showing that as much as 25 mg/ml of pSVERasN17 has no eect on the transcriptional eciency of the SV40 early promoter, as evaluated by the luciferase reporter gene. To further rule out the Figure 8 Eect of a c-Ha-Ras dominant interfering mutant, RasN17, on p53-dependent transactivation. (A,B) H1299 cells were transfected for 6 h with 2.5 mg/ml of pWWP-luc (A) pBAXluc (B) and 50 ng/ml pSVE-RenLuc (as internal control), with or without 10 mg/ml pSVEhump53 (wt-p53) and/or 17.5 mg/ml pSVE-RasN17 (RasN17) as indicated. (C) H1299 cells were transfected with 2.5 mg/ml pSVE-luc without (0) or with 10 (or 25) mg/ml psVE-RasN17. (D) H1299 cells were transfected with 1 mg/ml PG13-luc, 6 mg/ml pSVEhump53 and 50 ng/ml pSVERenLuc with or without 12 mg/ml pSVE-RasN17 and with or without 12 mg/ml RasV12 as indicated. Luciferase activity was normalized according to the Renilla luciferase activity as described in Materials and methods. The averaged results of six independent experiments performed in triplicate are shown with the standard deviation. Results in A, B and D are expressed taking as 1 the luciferase activity of parallel cultures transfected under the same amount of the various plasmids except pSVEhump53. The total amount of SV40 promoter was maintained constant in the control transfection mix by using the empty SV40 expression vector pUASori possibility of a general eect of RasN17 on protein stability, parallel experiments were performed by cotransfecting the plasmid encoding RasN17 with pUAS, a recombinant encoding SV40 Large T antigen (LTag). As for p53, accumulation of LTag was evaluated by Western blot. Results presented in Figure 9C indicate that, contrary to p53, the coexpression of RasN17 had no eect on the LTag protein level. We then conclude that the co-expression of a c-HaRas dominant interfering mutant speci®cally decreases the p53 protein accumulation. The RasN17 dosedependent decrease of p53 protein level directly correlates with a dose dependent diminution of both p53-dependent transcriptional activity and p53-mediated induction of apoptosis (data not shown). We then propose that the diminished level of p53 in cells co-expressing RasN17 might be attributed to greater protein instability that accounts for the diminution of both p53-mediated transcriptional activity and apoptosis.
Discussion
One of the most important roles of Ras is to be a regulator of cell proliferation and mitotic response to a variety of growth factors and oncogenes. But in certain situations, activation of Ras signalling pathways arrests the cell cycle rather than causing cell proliferation (Olson et al., 1998; Serrano et al., 1997) . Here we show that the c-Ha-Ras gene is directly transactivated by wtp53 and inhibiting Ras function can block that p53-mediated gene transactivation and p53-dependent apoptosis.
We previously identi®ed by computer analysis a p53RE within the 5' region of the ®rst intron of the human c-Ha-Ras gene (Bourdon et al., 1997) . This element is located within a region reported to be highly conserved between human and rodents and to have an enhance-like activity (Telliez et al., 1995) . In the present study, we report the presence of a p53RE in the 5' region of the ®rst intron of rat, mouse and rabbit c-Ha-Ras genes. We show that the p53RE isolated from human and mouse genes confers to a minimal promoter the ability to be transactivated by wt-p53 in a dose-dependent manner. Moreover, the expression of a reporter gene under the control of cHa-Ras p53RE element is stimulated in cells expressing wt but not mutant p53, after a stress. Additionally, we show an increased expression of the endogenous c-Ha-Ras gene in Saos-2Ts cells following temperature shift from 38 to 328C, both at the mRNA and protein levels. Finally, by using a novel cellular model derived from the human neuroblastoma cell line SK-N-SH (Smart et al., 1999) , we show that UVC treatment that induces p53-mediated apoptosis, gave rise to a p53-dependent p21 c-Ha-Ras increase in protein level. Altogether, these results show that c-Ha-Ras is a direct p53-target gene.
The fact that a functional p53RE is conserved for several species at the same genomic location argues for a physiological role of p53 in the regulation of c-HaRas gene expression and consequently to the possible involvement of the p21 c-Ha-Ras signalling pathway in some p53 functional activities. In agreement with this assumption, we showed a p53-dependent increase in the level of the activated form of p21 c-Ha-Ras in Saos-2Ts cells transferred to 328C, strongly suggesting that some p21 c-Ha-Ras dependent pathways could be activated in response to p53 activation. To further relate the p53-dependent up-regulation of c-Ha-Ras with the functional activity of this protein, we used the dominant interfering mutant Ha-RasN17 in which Ser-17 is replaced by Asn-17. The RasN17 protein is blocked in the inactive form Ras-GDP and cannot be activated. This mutant functions by titration of upstream activators of cellular Ha-Ras (Schweighoer et al., 1993) . It provides a way of blocking normal Ras functions so that the eects of interference with Rasmediated signal transduction can be analysed. As the three Ras proteins ± p21 c-Ha-Ras , p21
c-Ki-Ras and p21 N-Ras ± dier only in their carboxyl terminal part, Ha-RasN17 might also inhibit endogenous p21 c-Ki-Ras -and p21 N-Ras -dependent signal transduction. By using transient co-transfection of p53 with the dominant negative mutant Ha-RasN17, we show a substantial inhibition of both p53-dependent induction of apoptosis and p53-mediated transactivation of gene expression. The inhibition of p53 transcriptional activity by the co-expression of RasN17 is speci®c and does not depend on p53-responsive promoter since the same results were obtained for three distinct p53-responsive promoter elements. The cellular response to overexpression of RasN17 is not due to a cytotoxic eect or to a general inhibition of cellular transcription machinery, since basal activities of tested promoters are not reduced by the co-expression of RasN17 (results not shown). Taken together, these results suggest that some Ras-dependent transduction pathways of the transfected cells could be involved in the functional activities of the transiently expressed p53 protein.
p21 c-Ha-Ras activates several cascades of kinases (JNK, MAPK, PKCz) that can phosphorylate p53 in vitro and directly regulate its functional activity (Delphin and Baudier, 1994; Delphin et al., 1997; Hu et al., 1997; Milne et al., 1994 Milne et al., , 1995 Takenaka et al., 1995; Youmell et al., 1998) . By analysing the eect of eector mutants, Mazzoni et al. (1999) showed recently that Ras mediates sympathetic neuron survival via activation of PI3-K/Akt and Raf/MEK/MAPK signal pathways. In our experimental conditions, these Ras downstream eectors could not account for the observed negative regulatory eect of RasN17 since co-expression of the dominant-interfering forms of Raf, PI3K and MEKK has no eect on the level of apoptosis induced by transient expression of human wt-p53 (Deguin-Chambon, unpublished data).
We then hypothesized that the inhibitory eect of RasN17 could result in a reduced level of p53 protein in cells co-expressing RasN17. In agreement with this hypothesis, Western blot analysis of cells co-transfected with increased amounts of RasN17 clearly showed a dose-dependent decrease in p53 protein ( Figure 9A ). These results indicate that inactivation of p21 Transactivation of c-Ha-Ras by p53 and apoptosis V Deguin-Chambon et al transactivational silencing (Kamijo et al., 1998; Pomerantz et al., 1998; Stott et al., 1998; Zhang et al., 1998) . Therefore, we proposed that p21 c-Ha-Ras signalling pathways inhibits Mdm2 by activating the p19 ARF pathway. This is consistent with the recent observation showing that p19 ARF is required for the accumulation of p53 in response to oncogenic Ras . The increased rate of p53 degradation induced by coexpression of wt-p53 and RasN17 in H1299 that expressed a signi®cant amount of p14 ARF is consistent with the model presented in Figure  10 . By inducing the c-Ha-Ras gene, p53 activates a positive feedback loop that would counteract the p53-negative feedback loop mediated by Mdm2, and therefore leads to an enhancement of transcriptional activation of genes encoding mediators of p53-dependent cell death, such as Bax, IGF-BP3 and Fas, or involved in G1 arrest, such as the Cdk inhibitor p21 WAF1 (Ko and Prives, 1996; Levine, 1997) . In this model, the transcription of INK4a-ARF which is directly activated by E2F1 could be regulated either positively by c-Ha-Ras protein which regulates the cyclin D1 expression that, in association with Cdk, phosphorylates Rb and then releases E2F (Aktas et al., 1997) , or negatively by WAF1 protein which maintains the Rb-E2F complex (Leone et al., 1997; Peeper et al., 1997) . This negative eect may account for the down-regulation of p14 ARF expression observed in Saos-2 cells induced to express an exogenous p53 wt protein .
In conclusion, the results presented in this paper provide further evidence for the involvement of Rasdependent transduction pathways in the complex network of the cellular response to p53 activation. They suggest that, by inducing c-Ha-Ras, p53 activates a positive feedback loop that counteracts the negative feedback loop mediated by Mdm2.
Materials and methods

Plasmids
pSVEhump53 and pCMVhump53 are expression vectors of human wt-p53 under the control of the SV40 early (SVE) promoter and the cytomegalovirus immediate-early (CMV) promoter, respectively. The p53 sequence of both recombinants includes the complete human cDNA and the intron 4 at its position in the gene. These plasmids were described previously (Bourdon et al., 1997; Yonish-Rouach et al., 1994) . pSVE-p53Ser249, derived from pSVEhump53, encodes the human p53Ser249 mutant. pCMV-p53His175 encodes the human p53His175 mutant under the control of the CMV promoter. pUASori contains the SV40 early promoter inserted in pUC18. pUAS is a non-replicative T-antigenencoding recombinant. The pSVEHa-Ras N17 (pSVERasN17) plasmid is an expression vector of the human dominant negative mutant Ha-RasAsn17 (RasN17) under the control of the SV40 early promoter (Schweighoer et al., 1993) . The pHO6T1 plasmid encodes the Ha-RasV12 mutant (Cadoret et al., 1997) . The pWWP-luc plasmid (El-Deiry et al., 1993) contains 2400 bp of the human WAF1 gene promoter sequence inserted upstream of the luciferase gene. The pBAX-luc vector was constructed by inserting the SmaI/ SacI human BAX promoter fragment upstream of the luciferase gene of pGL3Basic (Promega) linearised by the KpnI/SacI double digestion (Miyashita and Reed, 1995) . PG13-luc contains 13 tandem copies of the RGC p53-binding element (Kern et al., 1991) in front of the luciferase reporter gene. The pAdluc plasmid was generated by cloning the minimum Adenovirus Major Late promoter sequence from pAdCAT (XbaI/HindIII) (Bourdon et al., 1997) upstream of the luciferase gene in pGL3-basic plasmid (Promega) (NheI/ HindIII). The pRasH-Adluc was constructed by inserting the 315-bp fragment containing the eight decamers identi®ed in the ®rst intron of the human c-Ha-Ras gene [positions 1052 to 1408 according to GenBank (HUMRASH)] upstream of the minimum Adenovirus Major Late promoter sequence of pAdluc. The 315-bp fragment was generated by PCR ampli®cation. To generate pRasM-Adluc, the intron 1 region of the mouse c-Ha-Ras gene containing the seven p53 consensus decamers [position 7573 to 7224 according to the published sequence of the mouse c-Ha-Ras enhancer (Brown et al., 1988) ] was ampli®ed and inserted upstream of the minimum Adenovirus Major Late promoter sequence of pAdluc. The plasmid pSVE-luc was generated by substituting the p53 cDNA contained in pSVEhump53 (HindIII/BamHI) by the luciferase gene from pGL3basic plasmid (Promega) (HindIII/BamHI). The plasmid pSVE-RenLuc was obtained from Promega (pRL-SV40 vector). The plasmid pSVERenNeo was constructed by replacing the Bg1II/XbaI CMV promoter fragment of pcDNA3 plasmid (Invitrogen) by the BglII/XbaI pSVE-RenLuc fragment containing the renilla luciferase reporter gene driven by the SV40 early promoter.
The Ras binding domain (RBD) of raf1 was expressed as glutathione S-transferase (GST) fusion protein in the JM109 Escherichia coli strain, transformed with the recombinant pGEX 2T-RBD recombinant (Herrmann et al., 1995) .
Cells and their treatment
The U-2OS cells (derived from a human osteosarcoma) expressed wt-p53. The HeLa cells derived from a cervical carcinoma in which HPV18-E6 continuously degrades wtp53. The non-expressing p53 used were Saos-2 cells (derived from a human osteosarcoma) and H1299 cells (derived from a human non small cell lung carcinoma). Cells were maintained at 378C in DMEM (HeLa, Saos-2, U-2OS) or RPMI (H1299) supplemented with 10% foetal calf serum (FCS). SKNSH-DDp53 and SKNSH-CMVNeo cell lines were already described (Smart et al., 1999) . They derived from SK-N-SH neuroblastoma cells transfected with plasmids pCMVNeop53DD and pCMV-Neo, respectively. The plasmid pCMVNeop53DD encodes a truncated mouse p53 including amino acid residues 1 ± 14 and 302 ± 390 (Shaulian et al., 1995) . The SKNSH-DDp53 and SKNSH-CMVNeo cells were maintained at 0.5 mg/ml G418 in DMEM supplemented with 10% FCS. Saos-2Ts cells were derived from p53-negative Saos-2 cells transfected with p53Val138, a human temperature-sensitive (ts) mutant expressed under the control of the CMV promoter (Yamato et al., 1995) . The Figure 10 Possible ways to account for the involvement of p53-mediated up-regulation of c-Ha-ras in the activation of p53. As a working hypothesis, we proposed that in the cellular context used in the present study, the p53-mediated up-regulation of c-Ha-Ras gene stimulated a feedback positive loop which, via the human p14 ARF (or the mouse homologue p19 ARF ), counteracts the negative eect of Mdm2
Saos-Neo cells were derived from Saos-2 cells transfected with the CMV-driven vector deleted for the p53 insert. They were maintained routinely at 388C in DMEM supplemented with 10% FCS.
U2OS-Rasluc and Saos-Rasluc were derived respectively from U-2OS and Saos-2 cells stably transfected with 5 mg/ml of pRasH-Adluc and 30 ng/ml of pSVERen-Neo plasmids. U2OS-Adluc and Saos-Adluc were derived respectively from U-2OS and Saos-2 cells stably transfected with 5 mg/ml of Adluc and 30 ng/ml of pSVERen-Neo plasmid. Cells were selected in the presence of G418 (Gibco, 0.5 mg/ml of culture medium) during 3 weeks.
Actinomycin D (Sigma), solubilized in ethanol, was added to the culture medium at a ®nal concentration of 60 ng/ml. Doxorubicin (Sigma), solubilized in DMSO, was added at a ®nal concentration of 0.2 mM. 1-(5-Isoquinolinesulfonyl)-2-methylpiperazine (H7, sigma), solubilized in H 2 O, was added at a ®nal concentration of 20 and 50 mM. Prior to UVC irradiation, medium was removed and the cell layer was irradiated with a germicidal lamp (254 nm, 30 J/m 2 ) and further grown in the original conditioned medium.
Monoclonal antibodies
The following p53-speci®c antibodies were used: PAb1801 (Oncogene Science, Ab2), PAb240 (Gannon et al., 1990) , DO7 (Stephen et al., 1995) and CM1 (Novocastra Laboratories Ltd). The monoclonal antibody PAb419 was used to reveal SV40 large T antigen (Crawford et al., 1982) . The antibody to p21 c-Ha-Ras was obtained from ViroMed Biosafety Laboratories (catalog no. LA069) and to Actin (Ab-1) from Calbiochem.
Luciferase assay
In a typical assay, 4610 5 cells were plated in 6-well plates (Falcon) and transfected with 400 ml of DNA-calcium phosphate precipitate as indicated in the legends to Figures. To each DNA-precipitate, the total DNA concentration was balanced to 30 mg/ml with pBS (Stratagene). After a 6 h incubation at 378C in the presence of the DNA precipitate, the cells were washed as previously described (Omilli et al., 1986) before incubation for an additional 18 h at 378C. The transfected cells were then washed twice with 2 ml of PBS buer and lysed directly by adding 400 ml/well of passive lysis buer (16) from the`Luciferase Assay' kit (Promega). After 15 min at room temperature, three aliquots of 20 ml/well of lysate were transferred to a 96-well microplate (Falcon 3296) and analysed in a Microlumat LB96P luminometer (Berthold EG&G Instrument) with the dual luciferase reporter assay (Promega), according to the manufacturer's protocol. Results are expressed as ®re¯y luciferase activity normalized to the Renilla luciferase activity.
Induction of p53-mediated apoptosis after transient transfection H1299 or HeLa cells (1610 6 ) were seeded in a 10-cm Petri dish and transfected with 1 ml of calcium precipitate as indicated in the legends to Figures. After incubation at 378C (48 h for H1299 cells or 66 h for HeLa cells), the cells were trypsinized, ®xed in 70% ethanol, immunostained and analysed by¯ow cytometry (FacScan, Becton Dickinson) as previously described (Yonish-Rouach et al., 1994) .
RNA extraction and Northern blot analysis
Total RNA was extracted according to Chomczyinski and Sacchi (1987) . Electrophoresis and Northern blot analysis were performed as previously described . A 590-bp KpnI-NheI human c-Ha-Ras DNA fragment isolated from the plasmid pEJ6,6 (Parada et al., 1982) and including exons 2 and 3 of the human c-Ha-Ras gene, a 1.4-kb SmaIfragment isolated from the plasmid p53-20 (Romano et al., 1989) and including the complete coding sequence of human p53 gene, a 2.1-kb EcoRI-fragment isolated from pZL-WAF1 (El-Deiry et al., 1993) and including the complete coding sequence of human waf1 gene and a 1.3-kb PstI cDNA fragment corresponding to the rat GAPDH gene were used as probes for Northern blot analysis. The relative level of the hybridization signal of speci®c mRNAs was evaluated with a Biorad GS 363 molecular imager.
48C for 15 min. The supernatant was collected and assayed for protein by the Bradford method. Supernatant corresponding to 1 mg of total proteins was incubated with mixing at 48C for 3.5 h with GST-RBD loaded gluthathione-Sepharose beads. Beads were washed four times with 1 ml of buer A and boiled with SDS-polyacrylamide gel electrophoresis sample buer [0.25 M Tris pH 6.8, 10% (w/v) SDS, 20% (v/v) glycerol, 10% (v/v) 2-mercaptoethanol, 0.001% bromophenol blue]. The eluted proteins were resolved on 12% polyacrylamide gel, transferred onto a nitrocellulose membrane and probed with monoclonal antibody to p21 c-Ha-Ras as described above.
